Rhumbline Advisers Staar Surgical CO Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Staar Surgical CO stock. As of the latest transaction made, Rhumbline Advisers holds 139,138 shares of STAA stock, worth $3.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139,138
Previous 146,775 5.2%
Holding current value
$3.71 Million
Previous $6.99 Million 26.03%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$29.97 - $47.42 $228,880 - $362,146
-7,637 Reduced 5.2%
139,138 $5.17 Million
Q2 2024

Aug 01, 2024
BUY
$38.07 - $52.25 $39,554 - $54,287
1,039 Added 0.71%
146,775 $6.99 Million
Q1 2024

May 09, 2024
BUY
$27.67 - $39.61 $12,949 - $18,537
468 Added 0.32%
145,736 $5.58 Million
Q4 2023

Feb 08, 2024
SELL
$30.6 - $43.78 $33,751 - $48,289
-1,103 Reduced 0.75%
145,268 $4.53 Million
Q3 2023

Nov 09, 2023
SELL
$39.39 - $58.12 $512,700 - $756,489
-13,016 Reduced 8.17%
146,371 $5.88 Million
Q2 2023

Aug 08, 2023
SELL
$50.45 - $72.82 $76,784 - $110,832
-1,522 Reduced 0.95%
159,387 $8.38 Million
Q1 2023

May 11, 2023
BUY
$51.25 - $79.34 $18,040 - $27,927
352 Added 0.22%
160,909 $10.3 Million
Q4 2022

Feb 14, 2023
BUY
$46.82 - $76.2 $273,709 - $445,465
5,846 Added 3.78%
160,557 $7.79 Million
Q3 2022

Nov 10, 2022
BUY
$70.55 - $111.58 $381,111 - $602,755
5,402 Added 3.62%
154,711 $10.9 Million
Q2 2022

Aug 11, 2022
BUY
$50.24 - $80.48 $489,136 - $783,553
9,736 Added 6.98%
149,309 $10.6 Million
Q1 2022

May 12, 2022
BUY
$57.98 - $93.5 $174,229 - $280,967
3,005 Added 2.2%
139,573 $11.2 Million
Q4 2021

Feb 10, 2022
BUY
$88.02 - $127.79 $43,393 - $63,000
493 Added 0.36%
136,568 $12.5 Million
Q3 2021

Nov 12, 2021
BUY
$122.75 - $162.68 $268,208 - $355,455
2,185 Added 1.63%
136,075 $17.5 Million
Q2 2021

Aug 05, 2021
SELL
$105.76 - $154.96 $63,244 - $92,666
-598 Reduced 0.44%
133,890 $20.4 Million
Q1 2021

May 06, 2021
BUY
$78.5 - $126.48 $5.39 Million - $8.69 Million
68,669 Added 104.33%
134,488 $14.2 Million
Q4 2020

Feb 10, 2021
BUY
$55.93 - $82.78 $145,977 - $216,055
2,610 Added 4.13%
65,819 $5.21 Million
Q3 2020

Nov 12, 2020
SELL
$45.65 - $61.81 $671,055 - $908,607
-14,700 Reduced 18.87%
63,209 $3.58 Million
Q2 2020

Aug 13, 2020
BUY
$29.15 - $61.54 $277,012 - $584,814
9,503 Added 13.89%
77,909 $4.8 Million
Q1 2020

May 06, 2020
SELL
$25.01 - $42.4 $173,069 - $293,408
-6,920 Reduced 9.19%
68,406 $2.21 Million
Q4 2019

Feb 05, 2020
BUY
$24.55 - $38.13 $50,990 - $79,196
2,077 Added 2.84%
75,326 $2.65 Million
Q3 2019

Oct 23, 2019
SELL
$25.78 - $34.8 $51,044 - $68,904
-1,980 Reduced 2.63%
73,249 $1.89 Million
Q2 2019

Aug 14, 2019
BUY
$23.08 - $37.01 $75,748 - $121,466
3,282 Added 4.56%
75,229 $2.21 Million
Q1 2019

May 01, 2019
BUY
$27.81 - $40.78 $84,486 - $123,889
3,038 Added 4.41%
71,947 $2.46 Million
Q4 2018

Jan 31, 2019
BUY
$28.91 - $50.0 $617,806 - $1.07 Million
21,370 Added 44.95%
68,909 $2.2 Million
Q3 2018

Nov 07, 2018
SELL
$30.85 - $50.65 $47,231 - $77,545
-1,531 Reduced 3.12%
47,539 $2.28 Million
Q2 2018

Aug 06, 2018
BUY
$13.95 - $32.65 $144,382 - $337,927
10,350 Added 26.73%
49,070 $1.52 Million
Q1 2018

May 02, 2018
SELL
$14.35 - $16.5 $13,273 - $15,262
-925 Reduced 2.33%
38,720 $573,000
Q4 2017

Feb 09, 2018
SELL
$12.45 - $17.4 $88,220 - $123,296
-7,086 Reduced 15.16%
39,645 $614,000
Q3 2017

Nov 06, 2017
BUY
$10.25 - $12.8 $478,992 - $598,156
46,731
46,731 $582,000

Others Institutions Holding STAA

# of Institutions
255
Shares Held
47.8M
Call Options Held
427K
Put Options Held
206K
View Full List

About STAAR SURGICAL CO

STAA Quotes by TradingView
  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email